Vogenx initiates Phase 2b EMERGE trial of mizagliflozin for post-bariatric hypoglycemiaNov 6Quarterly updatemizagliflozinVogenx, Inc.
Vogenx registers Phase 2b trial of mizagliflozin for post-bariatric hypoglycemiaAug 12Trial updatemizagliflozinVogenx, Inc.